Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ORIC has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
ORIC stock price ended at $5.57 on Thursday, after losing-2.45%
The Oric Pharmaceuticals Inc stock price decreased by -2.45% on the last trading day (01 May 2025), dropping from 5.67 to 5.57. Throughout the last trading session, the stock experienced a fluctuation of 7.48% , ranging from a day low of $5.35 to a day high of 5.75. The price has declined in 4 of the last 10 days, resulting in a total change of 18.76% during this period. On the last day, trading volume decrease by -112.95K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 611.39K shares were traded, amounting to approximately 3.41M.
ORIC Technical Signals
ORIC(Oric Pharmaceuticals Inc Corp) has 1 buy signal and 6 sell signals now. The current trend is downtrend starting from 2025-04-23. The total price change during this trend is +7.74%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of ORIC over the last 5 trading days is 3.43M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
ORIC Moving Average Analysis
Oric Pharmaceuticals Inc's overall moving average trend leans more bullish as of Friday, May 2, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $6.05108, and $6.5515. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $4.431919999999999, and $3.931499999999999. A break-down below any of these levels will issue sell signals.
ORIC Short Selling Analysis
The short sale ratio of Oric Pharmaceuticals Inc(ORIC) as of 30 Apr 2025 is 27.61%, rising from last trading day. With increasing price from 5.66 to 5.71. The short sell activity indicate that short sellers may be anticipating a price reversion.
Technical Signal
Technical Signals Summary
Strong sell
Sell
6
Buy
1
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
1 Bullish Signals
1 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Momentum (10 days)
MOM_10 > 0
0.88
Bullish
6 Bearish Signals
6 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 > 80
85.714
Bearish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
124.695
Bearish
Awesome Oscillator (5, 34)
AO_5_34 < 0
-0.37
Bearish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 < 0
-0.257
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
95.462
Bearish
Williams %R (14 days)
WILLR_14 > -20
-19.527
Bearish
ORIC Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Oric Pharmaceuticals Inc(ORIC), our algorithm predicts ORIC's 1-month price at $4.94, with an -3.09%downwardshift. Using a similarity score up to 98.36%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Oric Pharmaceuticals Inc (ORIC.O) stock, as of Sunday, April 27, 2025 , forecasts a -3.09% change over the next month, based on its high correlation with ERIC.O stock patterns. The similarity between their price movements over the analyzed periods is 98.36%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
ORIC
Future prediction
Up: -3.09%
ERIC
Down: -3.09%Similarity: 98.36%
Name
Similarity
Up/Down
ERIC.O
98.36%
-3.09%
HTCO.O
98.19%
-27.13%
EXE.O
98.18%
+9.57%
SM.N
98.10%
-27.73%
EDIT.O
98.08%
+35.26%
HOOK.O
98.07%
-29.17%
LNZA.O
98.06%
-2.33%
AORT.N
97.90%
+1.48%
FARM.O
97.85%
-13.40%
KTTA.O
97.85%
-16.07%
ORIC Seasonality Analysis
Based on ORIC's historical stock price data across all years, the probability of a positive return in May is40.00%, suggesting it maynotbe an ideal month to invest in ORIC. In contrast,Novemberoffers the highest probability of positive returns at80.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Oric Pharmaceuticals Inc (ORIC.O) stock in November has the highest probability of a positive return (80.00%), while September has the lowest probability (0.00%).
Performance Seasonality
The chart shows Oric Pharmaceuticals Inc. (ORIC)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Oric Pharmaceuticals Inc (ORIC.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. ORIC has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Oric Pharmaceuticals Inc (ORIC.O) stock in a year?
The radar chart shows that buying Oric Pharmaceuticals Inc (ORIC.O) stock in November has the highest probability of a positive return (80.00%), while September has the lowest probability (0.00%).
How has Oric Pharmaceuticals Inc. (ORIC)'s stock price performed over the past three years?
ORIC's stock price rose by 53.59% in 2023,decreased by -11.71% in 2024, and went down by 32.57% in 2025.
Which bull technical signals does ORIC have?
Bullish technical signals of ORIC include: MOM_10 > 0.
Is ORIC a buy based on overall technical signals summary?
ORIC has 1 buy signals and 6 sell signals now. Overall the technical rating for ORIC is Strong sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of ORIC.
What is the trend of Oric Pharmaceuticals Inc (ORIC)'s moving average?
Oric Pharmaceuticals Inc's overall moving average trend leans more bullish as of May 02 2025, with 2 negative signals and 2 positive signal.
What is price prediction for ORIC stock next month?
The price prediction chart for Oric Pharmaceuticals Inc (ORIC.O) stock, as of April 27 2025, forecasts a -3.09% change over the next month, based on its high correlation with ERIC stock patterns. The similarity between their price movements over the analyzed periods is 98.36%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for ORIC Stock?
ORIC Pharmaceuticals' stock is expected to reach **$18.00** by the end of 2025, driven by positive clinical trial data for ORIC-944 and ORIC-114, with analysts maintaining a Strong Buy rating and a consensus price target of $18.00.
What is price prediction 2030 for ORIC Stock?
ORIC Pharmaceuticals (ORIC) stock is predicted to reach **$25 by 2030**, driven by its focused clinical development plans for ORIC-944 and ORIC-114, which target significant unmet needs in oncology. Analysts maintain a **$21 price target**, reflecting confidence in its pipeline potential. The stock is expected to rise as it progresses through registrational trials and achieves key milestones.